denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Program: Scientific Workshops
Session: Clonal Hematopoiesis Lesions and Gene Editing
Disclosures: Majeti: Kodikaz Therapeutic Solutions, Orbital Therapeutics, Pheast Therapeutics,: Membership on an entity's Board of Directors or advisory committees; Aculeus Therapeutics: Membership on an entity's Board of Directors or advisory committees; 858 Therapeutics: Membership on an entity's Board of Directors or advisory committees; Mubadala Capital: Membership on an entity's Board of Directors or advisory committees; Prelude Therapeutics: Membership on an entity's Board of Directors or advisory committees; Orbital Therapeutics: Membership on an entity's Board of Directors or advisory committees; Pheast Therapeutics: Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees; MyeloGene: Current equity holder in publicly-traded company; Orbital Therapeutics: Current equity holder in private company.
See more of: Scientific Workshop on Clonal Hematopoiesis
See more of: Scientific Workshops